These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37494056)

  • 41. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    Serrano PE; Gu CS; Moulton CA; Husien M; Jalink D; Martel G; Tsang ME; Hallet J; McAlister V; Gallinger S; Levine M
    J Surg Oncol; 2020 May; 121(6):1001-1006. PubMed ID: 32034769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver Transplantation as a Curative Approach for Patients With Nonresectable Colorectal Liver Metastases.
    Ahmed FA; Kwon YK; Zielsdorf S; Cooper JT; Aziz H
    Exp Clin Transplant; 2022 Feb; 20(2):113-121. PubMed ID: 35282808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group.
    Liersch T; Meller J; Bittrich M; Kulle B; Becker H; Goldenberg DM
    Ann Surg Oncol; 2007 Sep; 14(9):2577-90. PubMed ID: 17570017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is Cure Possible After Sequential Resection of Hepatic and Pulmonary Metastases From Colorectal Cancer?
    Rajakannu M; Magdeleinat P; Vibert E; Ciacio O; Pittau G; Innominato P; SaCunha A; Cherqui D; Morère JF; Castaing D; Adam R
    Clin Colorectal Cancer; 2018 Mar; 17(1):41-49. PubMed ID: 28709876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    Dupré A; Rehman A; Jones RP; Parker A; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    J Surg Oncol; 2018 May; 117(6):1330-1336. PubMed ID: 29315600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.
    Liu W; Wang HW; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Aug; 45(8):1349-1356. PubMed ID: 31054852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.
    Herrick-Reynolds KM; Punchhi G; Greenberg RS; Strauss AT; Boyarsky BJ; Weeks-Groh SR; Krach MR; Anders RA; Gurakar A; Chen PH; Segev DL; King EA; Philosophe B; Ottman SE; Wesson RN; Garonzik-Wang JM; Cameron AM
    JAMA Surg; 2021 Nov; 156(11):1026-1034. PubMed ID: 34379106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer.
    Hagness M; Foss A; Egge TS; Dueland S
    Ann Surg Oncol; 2014 Apr; 21(4):1323-9. PubMed ID: 24370906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
    Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
    Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial.
    Katipally RR; Martinez CA; Pugh SA; Bridgewater JA; Primrose JN; Domingo E; Maughan TS; Talamonti MS; Posner MC; Weichselbaum RR; Pitroda SP;
    JAMA Oncol; 2023 Sep; 9(9):1245-1254. PubMed ID: 37471075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
    Fong Y; Fortner J; Sun RL; Brennan MF; Blumgart LH
    Ann Surg; 1999 Sep; 230(3):309-18; discussion 318-21. PubMed ID: 10493478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
    Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of patient selection policy and pattern of recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis.
    Robella M; Vaira M; Borsano A; DE Simone M
    Minerva Chir; 2018 Apr; 73(2):133-141. PubMed ID: 29397633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.